This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Martin Bröeckelmann: Innovator in Pharmaceutical Chemistry
Introduction
Martin Bröeckelmann is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work focuses on creating effective solutions for various medical conditions.
Latest Patents
Martin Bröeckelmann holds a patent for "Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use." This invention relates to crystalline hydrates of a specific formula, where the variable n ranges from 2.1 to 2.5. The compound is particularly suitable for use as an antidiabetic medication. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Bröeckelmann is currently employed at Sanofi, a leading global healthcare company. His role involves research and development, where he applies his knowledge to create innovative pharmaceutical solutions. His work has the potential to impact the lives of many patients suffering from diabetes and other related conditions.
Collaborations
Some of his notable coworkers include Bernd Becker and Franceska Fischer. Together, they contribute to the advancement of pharmaceutical research and development within their organization.
Conclusion
Martin Bröeckelmann is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His innovative approach and dedication to research are commendable, and his contributions will likely have a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile